Tranexamic acid: a novel oral formulation for the treatment of heavy menstrual bleeding - PubMed (original) (raw)

Review

doi: 10.2217/whe.11.9.

Affiliations

• PMID: 21410342
• DOI: 10.2217/whe.11.9

Free article

Review

Tranexamic acid: a novel oral formulation for the treatment of heavy menstrual bleeding

Andrea S Lukes et al. Womens Health (Lond). 2011 Mar.

Free article

Abstract

Tranexamic acid, a synthetic lysine derivative, is an antifibrinolytic drug that prevents the breakdown of fibrin by competitively blocking binding sites of plasminogen. Tranexamic acid is often considered a first-line treatment for the management of heavy menstrual bleeding (HMB). A new oral formulation of tranexamic acid provides a nonhormonal HMB therapy that is safe, effective and well tolerated; is administered only during menstruation; addresses the excessive fibrinolysis implicated in many cases of HMB; and improves women's health-related quality of life by reducing limitations on physical, social and leisure activities. This article provides a summary of the clinical development, therapeutic efficacy and tolerability profile of this novel formulation of tranexamic acid for the treatment of HMB.

PubMed Disclaimer

Similar articles

• Tranexamic acid therapy for heavy menstrual bleeding.
  Lumsden MA, Wedisinghe L. Lumsden MA, et al. Expert Opin Pharmacother. 2011 Sep;12(13):2089-95. doi: 10.1517/14656566.2011.598857. Epub 2011 Jul 18. Expert Opin Pharmacother. 2011. PMID: 21767224 Review.
• Oral modified-release tranexamic acid for heavy menstrual bleeding.
  Hrometz SL. Hrometz SL. Ann Pharmacother. 2012 Jul-Aug;46(7-8):1047-53. doi: 10.1345/aph.1R025. Epub 2012 Jul 17. Ann Pharmacother. 2012. PMID: 22811348 Review.
• Daily menstrual blood loss and quality of life in women with heavy menstrual bleeding.
  Lukes AS, Baker J, Eder S, Adomako TL. Lukes AS, et al. Womens Health (Lond). 2012 Sep;8(5):503-11. doi: 10.2217/whe.12.36. Womens Health (Lond). 2012. PMID: 22934724
• Tranexamic acid: a review of its use in the management of menorrhagia.
  Wellington K, Wagstaff AJ. Wellington K, et al. Drugs. 2003;63(13):1417-33. doi: 10.2165/00003495-200363130-00008. Drugs. 2003. PMID: 12825966 Review.
• Antifibrinolytics for heavy menstrual bleeding.
  Lethaby A, Farquhar C, Cooke I. Lethaby A, et al. Cochrane Database Syst Rev. 2000;(4):CD000249. doi: 10.1002/14651858.CD000249. Cochrane Database Syst Rev. 2000. PMID: 11034679 Updated. Review.

Cited by

• U.S. Selected Practice Recommendations for Contraceptive Use, 2024.
  Curtis KM, Nguyen AT, Tepper NK, Zapata LB, Snyder EM, Hatfield-Timajchy K, Kortsmit K, Cohen MA, Whiteman MK; Contributors. Curtis KM, et al. MMWR Recomm Rep. 2024 Aug 8;73(3):1-77. doi: 10.15585/mmwr.rr7303a1. MMWR Recomm Rep. 2024. PMID: 39106301 Free PMC article.
• Discovery of the Fibrinolysis Inhibitor AZD6564, Acting via Interference of a Protein-Protein Interaction.
  Cheng L, Pettersen D, Ohlsson B, Schell P, Karle M, Evertsson E, Pahlén S, Jonforsen M, Plowright AT, Boström J, Fex T, Thelin A, Hilgendorf C, Xue Y, Wahlund G, Lindberg W, Larsson LO, Gustafsson D. Cheng L, et al. ACS Med Chem Lett. 2014 Feb 18;5(5):538-43. doi: 10.1021/ml400526d. eCollection 2014 May 8. ACS Med Chem Lett. 2014. PMID: 24900876 Free PMC article.
• Design, synthesis and in vitro kinetic study of tranexamic acid prodrugs for the treatment of bleeding conditions.
  Karaman R, Ghareeb H, Dajani KK, Scrano L, Hallak H, Abu-Lafi S, Mecca G, Bufo SA. Karaman R, et al. J Comput Aided Mol Des. 2013 Jul;27(7):615-35. doi: 10.1007/s10822-013-9666-2. Epub 2013 Jul 24. J Comput Aided Mol Des. 2013. PMID: 23881217
• Recent advances on plasmin inhibitors for the treatment of fibrinolysis-related disorders.
  Al-Horani RA, Desai UR. Al-Horani RA, et al. Med Res Rev. 2014 Nov;34(6):1168-216. doi: 10.1002/med.21315. Epub 2014 Mar 21. Med Res Rev. 2014. PMID: 24659483 Free PMC article. Review.
• A Comprehensive Review of the Pharmacologic Management of Uterine Leiomyoma.
  Lewis TD, Malik M, Britten J, San Pablo AM, Catherino WH. Lewis TD, et al. Biomed Res Int. 2018 Jan 28;2018:2414609. doi: 10.1155/2018/2414609. eCollection 2018. Biomed Res Int. 2018. PMID: 29780819 Free PMC article. Review.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Atypon
  • Ovid Technologies, Inc.

• Other Literature Sources

  • The Lens - Patent Citations Database